Journal
JOURNAL OF REHABILITATION MEDICINE
Volume 41, Issue 1, Pages 13-25Publisher
FOUNDATION REHABILITATION INFORMATION
DOI: 10.2340/16501977-0303
Keywords
botulinum toxin; upper motor neurone syndrome; adult spasticity; acquired brain injury
Categories
Funding
- Allergan
- Ipsen
- Merz
- Elan
- Medtronic
- Novartis
- Boehringer
Ask authors/readers for more resources
A group of clinicians from across Europe experienced in the use of botulinum toxin type a for the treatment of spasticity following acquired brain injury gathered to develop a consensus statement on best practice in managing adults with spasticity. this consensus table summarizes the current published data, which was collated following extensive literature searches, their assessment for level of evidence and discussion among the whole group. published information is supplemented by expert opinion based on clinical experience from 16 European countries, involving 28 clinicians, who treat an average of approximately 200 patients annually, representing many thousand spasticity treatments with botulinum toxin per year.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available